|
⚲
|
| Keyboard |
| Dyrness Albert D
✚
|
|
|---|---|
| CIK # | 0001664801 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001664801] | |
| 4 | [0001664801] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dyrness Albert D | |
| Hyperliquid Strategies Inc | |
| Sonnet BioTherapeutics Holdings Inc | |
| Outlook Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Hyperliquid Strategies Inc PURR
Common Stock
|
2026-02-09 | Grant | 40,789 | $0.00 | |
|
Hyperliquid Strategies Inc PURR
Common Stock
|
2025-12-02 | Other | 882 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2025-12-02 | Disposed to issuer | 4,537 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2023-12-11 | Grant | 373 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2023-07-11 | Grant | 4,000 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2023-05-30 | Buy | 23,255 | $0.47 | 10,930 |
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2022-12-14 | Grant | 3,770 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2021-12-15 | Grant | 14,152 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2020-07-02 | Grant | 8,005 | $0.00 | |
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2020-06-11 | Buy | 2,409 | $4.01 | 9,660 |
|
Sonnet BioTherapeutics Holdings Inc SONN
Warrant to Purchase Common Stock · derivative
|
2020-04-01 | Grant | 1,279 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2020-04-01 | Grant | 2,557 | ||
|
Outlook Therapeutics Inc ONS
Stock Option (Right to Buy) · derivative
|
2017-10-26 | Grant | 15,000 | $0.00 | |
|
Outlook Therapeutics Inc ONS
Warrant (Right to Buy) · derivative
|
2016-12-22 | Buy | 11,500 |